FibroGen Inc’s recent filing unveils that its Director Schoeneck James A acquired Company’s shares for reported $88000.0 on Mar 20 ’25. In the deal valued at $0.35 per share,250,000 shares were bought. As a result of this transaction, Schoeneck James A now holds 323,722 shares worth roughly $0.12 million.
Then, Schoeneck James A bought 50,000 shares, generating $17,040 in total proceeds. Upon buying the shares at $0.34, the Director now owns 373,722 shares.
Before that, Adib Deyaa bought 22,123 shares. FibroGen Inc shares valued at $25,884 were divested by the Chief Medical Officer at a price of $1.17 per share. As a result of the transaction, Adib Deyaa now holds 82,123 shares, worth roughly $30385.51.
BofA Securities downgraded its FibroGen Inc [FGEN] rating to an Underperform from a a Neutral in a research note published on August 08, 2023; the price target was decreased to $2 from $4. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in late June from “an Outperform” to “a Mkt perform”. Stifel also remained covering FGEN and has decreased its forecast on June 26, 2023 with a “Hold” recommendation from previously “Buy” rating. Raymond James revised its rating on June 26, 2023. It rated FGEN as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of FGEN
On Monday, FibroGen Inc [NASDAQ:FGEN] saw its stock jump 17.14% to $0.37. Over the last five days, the stock has lost -17.08%. FibroGen Inc shares have fallen nearly -30.31% since the year began. Nevertheless, the stocks have fallen -84.36% over the past one year. While a 52-week high of $2.80 was reached on 02/20/25, a 52-week low of $0.18 was recorded on 03/21/25. SMA at 50 days reached $0.4825, while 200 days put it at $0.5421.
Levels Of Support And Resistance For FGEN Stock
The 24-hour chart illustrates a support level at 0.3360, which if violated will result in even more drops to 0.3030. On the upside, there is a resistance level at 0.3910. A further resistance level may holdings at 0.4130. The Relative Strength Index (RSI) on the 14-day chart is 43.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0489, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.39%. Stochastics %K at 18.35% indicates the stock is a buying.
How much short interest is there in FibroGen Inc?
A steep rise in short interest was recorded in FibroGen Inc stocks on 2025-02-28, growing by 2.39 million shares to a total of 5.3 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 2.91 million shares. There was a rise of 45.17%, which implies that there is a positive sentiment for the stock.
